Marie A Flannery1, Supriya Mohile2, Eva Culakova2, Sally Norton3, Charles Kamen2, J Nicholas Dionne-Odom4, Grace DiGiovanni2, Lorraine Griggs5, Thomas Bradley6, Judith O Hopkins7, Jane Jijun Liu8, Kah Poh Loh2. 1. School of Nursing (M.A.F., S.N.), University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. Electronic address: marie_flannery@urmc.rochester.edu. 2. University of Rochester School of Medicine and Dentistry (S.M., E.C., C.K., G.D., K.P.L.), Rochester, New York, USA. 3. School of Nursing (M.A.F., S.N.), University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. 4. University of Alabama (J.N.D.-O.), Birmingham, School of Nursing, Birmingham, Alabama, USA. 5. University of Rochester Medical Center (L.G.), SCOREBOARD, Patient Advisory Board, Rochester, New York, USA. 6. Northwell Health NCORP (T.B.), New York, New York, USA. 7. Southeast Clinical Oncology Research Consortium NCORP (J.O.H.), Winston Salem, North Carolina, USA. 8. Illinois Cancer Care and Heartland NCORP (J.J.L.), Illnois, USA.
Abstract
CONTEXT: Systematic collection of patient-reported outcomes (PROs) reduces symptom burden and improves quality of life. The ability of older adults to complete PROs, however, has not been thoroughly studied. OBJECTIVES: To determine whether older adults with advanced cancer received assistance completing PROs, the nature of the assistance, the factors associated with receiving assistance, and how the prevalence of assistance changed over time. METHODS: Data were obtained from a multisite cluster randomized controlled study of geriatric assessment (Clinicaltrials.gov: NCT02107443). Adults ≥70 years with advanced cancer completed multiple PROs at 4 time points (enrollment, 6 weeks, 3 months, 6 months). Factors associated with receipt of assistance were assessed with bivariate and multivariate analyses. RESULTS: The study included 541 adults (range 70-96 years, 49% female, mixed incurable cancer diagnoses). Twenty-eight percent (153/541) received assistance completing PROs. Of these, 42% received assistance from caregivers, 37% from research staff, and 15% from both. Factors associated with receiving assistance included older age [Adjusted Odds Ratio (AOR) 3.71, 95% Confidence Interval (CI) 1.03-13.38], lower education level (3.92, 2.11-7.29), impaired cognition (1.90, 1.23-2.93), impaired functional status (2.16, 1.33-3.52), and impaired hearing (1.38, 1.05-1.80). Eighty percent of individuals who received assistance were identified at study initiation. Receiving assistance decreased over time from 28% to 18%, partially due to drop-outs. CONCLUSION: Over a quarter of older adults with advanced cancer in this study received assistance completing PROs. Completing PROs is a key aspect of many clinical programs and cancer trials; assistance in completing PROs should be offered and provided.
CONTEXT: Systematic collection of patient-reported outcomes (PROs) reduces symptom burden and improves quality of life. The ability of older adults to complete PROs, however, has not been thoroughly studied. OBJECTIVES: To determine whether older adults with advanced cancer received assistance completing PROs, the nature of the assistance, the factors associated with receiving assistance, and how the prevalence of assistance changed over time. METHODS: Data were obtained from a multisite cluster randomized controlled study of geriatric assessment (Clinicaltrials.gov: NCT02107443). Adults ≥70 years with advanced cancer completed multiple PROs at 4 time points (enrollment, 6 weeks, 3 months, 6 months). Factors associated with receipt of assistance were assessed with bivariate and multivariate analyses. RESULTS: The study included 541 adults (range 70-96 years, 49% female, mixed incurable cancer diagnoses). Twenty-eight percent (153/541) received assistance completing PROs. Of these, 42% received assistance from caregivers, 37% from research staff, and 15% from both. Factors associated with receiving assistance included older age [Adjusted Odds Ratio (AOR) 3.71, 95% Confidence Interval (CI) 1.03-13.38], lower education level (3.92, 2.11-7.29), impaired cognition (1.90, 1.23-2.93), impaired functional status (2.16, 1.33-3.52), and impaired hearing (1.38, 1.05-1.80). Eighty percent of individuals who received assistance were identified at study initiation. Receiving assistance decreased over time from 28% to 18%, partially due to drop-outs. CONCLUSION: Over a quarter of older adults with advanced cancer in this study received assistance completing PROs. Completing PROs is a key aspect of many clinical programs and cancer trials; assistance in completing PROs should be offered and provided.
Authors: Ethan Basch; Allison M Deal; Amylou C Dueck; Howard I Scher; Mark G Kris; Clifford Hudis; Deborah Schrag Journal: JAMA Date: 2017-07-11 Impact factor: 56.272
Authors: Sharon M Licqurish; Olivia Y Cook; Loyal P Pattuwage; Christobel Saunders; Michael Jefford; Bogda Koczwara; Claire E Johnson; Jon D Emery Journal: CA Cancer J Clin Date: 2019-07-24 Impact factor: 508.702
Authors: Allison Magnuson; Heather Allore; Harvey Jay Cohen; Supriya G Mohile; Grant R Williams; Andrew Chapman; Martine Extermann; Rebecca L Olin; Valerie Targia; Amy Mackenzie; Holly M Holmes; Arti Hurria Journal: J Geriatr Oncol Date: 2016-07-05 Impact factor: 3.599
Authors: Benjamin D Smith; Grace L Smith; Arti Hurria; Gabriel N Hortobagyi; Thomas A Buchholz Journal: J Clin Oncol Date: 2009-04-29 Impact factor: 44.544
Authors: Ethan Basch; Allison M Deal; Mark G Kris; Howard I Scher; Clifford A Hudis; Paul Sabbatini; Lauren Rogak; Antonia V Bennett; Amylou C Dueck; Thomas M Atkinson; Joanne F Chou; Dorothy Dulko; Laura Sit; Allison Barz; Paul Novotny; Michael Fruscione; Jeff A Sloan; Deborah Schrag Journal: J Clin Oncol Date: 2015-12-07 Impact factor: 44.544
Authors: Victor T Chang; Shirley S Hwang; Howard T Thaler; Basil S Kasimis; Russell K Portenoy Journal: Expert Rev Pharmacoecon Outcomes Res Date: 2004-04 Impact factor: 2.217
Authors: Marije E Hamaker; Marthe Te Molder; Noortje Thielen; Barbara C van Munster; Anandi H Schiphorst; Lieke H van Huis Journal: J Geriatr Oncol Date: 2018-04-07 Impact factor: 3.599
Authors: Kah Poh Loh; Supriya G Mohile; Jennifer L Lund; Ronald Epstein; Lianlian Lei; Eva Culakova; Colin McHugh; Megan Wells; Nikesha Gilmore; Mostafa R Mohamed; Charles Kamen; Valerie Aarne; Alison Conlin; James Bearden; Adedayo Onitilo; Marsha Wittink; William Dale; Arti Hurria; Paul Duberstein Journal: Oncologist Date: 2019-04-23
Authors: Supriya G Mohile; Ronald M Epstein; Arti Hurria; Charles E Heckler; Beverly Canin; Eva Culakova; Paul Duberstein; Nikesha Gilmore; Huiwen Xu; Sandy Plumb; Megan Wells; Lisa M Lowenstein; Marie A Flannery; Michelle Janelsins; Allison Magnuson; Kah Poh Loh; Amber S Kleckner; Karen M Mustian; Judith O Hopkins; Jane Jijun Liu; Jodi Geer; Rita Gorawara-Bhat; Gary R Morrow; William Dale Journal: JAMA Oncol Date: 2020-02-01 Impact factor: 31.777
Authors: Rebecca E Ryan; Michael Connolly; Natalie K Bradford; Simon Henderson; Anthony Herbert; Lina Schonfeld; Jeanine Young; Josephine I Bothroyd; Amanda Henderson Journal: Cochrane Database Syst Rev Date: 2022-07-08
Authors: Peter M Anderson; Stefanie M Thomas; Shauna Sartoski; Jacob G Scott; Kaitlin Sobilo; Sara Bewley; Laura K Salvador; Maritza Salazar-Abshire Journal: Nutrients Date: 2021-12-08 Impact factor: 5.717